ARID3C

ARID3C is an ARID3-subfamily transcription factor whose REKLES domain mediates self-association, heterodimerization with ARID3A and ARID3B, nuclear matrix targeting, and CRM1-dependent nucleocytoplasmic shuttling (PMID:17400556). In B cells, ARID3C co-activates ARID3A-dependent immunoglobulin heavy chain transcription, with maximal activity conferred by its unsumoylated form, and relocalizes to lipid rafts upon BCR stimulation (PMID:21955986). In myeloid cells, ARID3C binds NPM1 to gain nuclear entry, where it directly activates STAT3, STAT1, and JUNB promoters to drive monocyte-to-macrophage differentiation (PMID:38231884).

1. 2007 High

   Establishing that ARID3C possesses a functional REKLES domain resolved how this newly identified paralogue achieves nuclear-cytoplasmic shuttling and interacts with ARID3A/3B, defining it as a bona fide ARID3 subfamily member with distinct domain-dependent trafficking.

   Evidence Domain mutagenesis, nuclear-cytoplasmic fractionation, multimerization and DNA binding assays in transfected cells

   PMID:17400556

   Open questions at the time

   • No endogenous physiological context for ARID3C function was established
   • Whether ARID3C directly binds DNA at specific genomic targets was not resolved
   • Mechanism of nuclear import partner recruitment unknown
2. 2011 High

   Demonstrating that ARID3C co-occupies immunoglobulin heavy chain regulatory elements with ARID3A and co-activates IgH transcription established a direct transcriptional role in B-cell biology, while revealing SUMO-I modification as a negative regulatory mechanism.

   Evidence Co-IP, ChIP, in vitro DNA binding, transcription reporter assays, SUMO modification assay, and subcellular fractionation in B-cell lines

   PMID:21955986

   Open questions at the time

   • Whether ARID3C is required for IgH expression in vivo (e.g., knockout B cells) was not tested
   • Mechanism by which SUMO modification suppresses transcriptional co-activation is unknown
   • Lipid raft relocalization upon BCR stimulation was not functionally linked to transcriptional output
3. 2019 Low

   Proximity-based identification of ARID3C in a complex with β-catenin, α-catenin, E-cadherin, and PTPRR in ovarian cancer cells raised the possibility of a role at the Wnt/β-catenin–cell adhesion interface, though no direct functional follow-up on ARID3C was performed.

   Evidence BioID proximity tagging and proximity ligation assay in ovarian cancer cells

   PMID:31653698

   Open questions at the time

   • No direct functional validation of ARID3C within this complex was performed
   • Whether ARID3C modulates Wnt/β-catenin signaling output is untested
   • Proximity labeling does not confirm direct physical interaction
4. 2024 Medium

   Identification of NPM1 as the nuclear import chaperone for ARID3C, and demonstration that ARID3C directly activates STAT3/STAT1/JUNB promoters during macrophage differentiation, extended its transcription factor role beyond B cells into myeloid lineage commitment.

   Evidence LC-MS/MS interactome, co-IP, site-directed mutagenesis of NPM1 binding interface, ChIP, subcellular fractionation, and loss-of-function differentiation assays in monocytic cells

   PMID:38231884

   Open questions at the time

   • AlphaFold2-predicted binding interface awaits experimental structural validation
   • Whether NPM1-dependent import also operates in B cells or other lineages is unknown
   • In vivo requirement for ARID3C in myeloid differentiation has not been tested
5. 2024 Medium

   Conditional knockout of Arid3c in mouse spinal cord revealed a role in locomotor circuit formation without affecting neuronal fate specification, extending ARID3C function to neurodevelopment.

   Evidence Arid3c conditional knockout mouse, in situ hybridization, immunostaining, and locomotor behavioral analysis

   PMID:39479525

   Open questions at the time

   • Transcriptional targets of ARID3C in spinal interneurons are unidentified
   • Whether the locomotor phenotype reflects cell-autonomous transcriptional activity or non-autonomous signaling is unclear
   • The V2 interneuron subset marked by Arid3c remains molecularly uncharacterized

• The genome-wide direct target repertoire of ARID3C across cell types, the structural basis of its DNA binding and NPM1 interaction, and whether its myeloid and neural functions depend on the same REKLES-mediated partnerships as in B cells remain unresolved.
• No genome-wide binding profile (ChIP-seq) exists for ARID3C in any cell type
• No crystal or cryo-EM structure of ARID3C or its complexes has been determined
• Functional relationship between ARID3C's roles in B cells, macrophages, neurons, and epithelial Wnt signaling is unexplored